Molnupiravir, the first oral antiviral for treatment of mild to moderate Covid approved by the US Food and Drug Administration (FDA), seems to have bombed in the domestic market.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3dxapgr
No comments:
Post a Comment